Mezera 500 mg (Mesalazine TABLET (DELAYED-RELEASE)) 500 MG

MEZERA 500 MG is a delayed-release tablet containing mesalazine, used for managing inflammatory conditions. This medication is designed to provide targeted relief and support gastrointestinal health.

Strength

500 MG

Manufacturer / TM Owner

AVIR PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MEZERA 500 MG is primarily used for the treatment of inflammatory bowel diseases, such as ulcerative colitis. It helps to reduce inflammation in the colon and rectum, promoting healing and symptom relief. People often ask, 'What is MEZERA 500 MG used for?' It is commonly prescribed to manage flare-ups and maintain remission in chronic inflammatory conditions.

Side Effects

MEZERA 500 MG may cause common side effects such as nausea, vomiting, and abdominal pain. Some users might experience headaches or diarrhea. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle MEZERA 500 MG with care, following the prescribed dosage and administration instructions. Avoid crushing or chewing the delayed-release tablets, as this can affect their effectiveness. Store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

MEZERA 500 MG may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other gastrointestinal treatments. Alcohol consumption should be moderated, as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

MEZERA 500 MG is used to manage inflammatory bowel diseases, such as ulcerative colitis, by reducing inflammation in the colon and rectum.

MEZERA 500 MG should be taken orally with a full glass of water, preferably with food. Do not crush or chew the tablets.

Common side effects may include nausea, vomiting, abdominal pain, headaches, and diarrhea. These effects vary among individuals.

It is advisable to moderate alcohol consumption while taking MEZERA 500 MG, as it can exacerbate side effects.

Store MEZERA 500 MG in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.